IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
Population Health sheds light on significant variations in birthweights among Hispanic subgroups in New York City, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback